
December 2022
By Nicole Bootsman, PRP Manager,
and Sheila Torrance, Legal Counsel, CPSS |
|
Amendments to OATP Standards and Guidelines/Policy re Buprenorphine/naloxone prescribing for MAINTAINING (Non-Initiating) Physicians for Opioid Use Disorder
In response to a request for urgent review, Council has amended the educational requirement for buprenorphine/naloxone maintenance prescribing for the treatment of opioid use disorder. The previously required OAT course/workshop is now strongly recommended rather than mandatory. READ MORE
|